FDA Turns to Emerging Tech to Better Connect Researchers

FDA Turns to Emerging Tech to Better Connect Researchers

Cory Milam
Director of the Office of Innovation, FDA

The Food and Drug Administration is excited about emerging technologies and its potential to better connect its scientists and researchers with data-driven decision-making. Some of its centers are exploring the use of blockchain to get evaluations done between external parties and FDA in a secure manner, and the administration as a whole is looking at electronic health record modification and its impact on patient-data access.